Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ACON · NASDAQ · Services-Medical Laboratories
Aclarion (ACON) · oqro.io/stocks/ACON · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.56−0.03 (−1.89%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
9 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
6 insiders in a week, a first since 2022Traded Aug 17 · filed 2 days later
Since the trade −43.7% · S&P 500 −2.4% · to Nov 13
An Aclarion director paid $16K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month. Shares held went up 29% with this purchase.
Insider buying
5 insiders in a week, a first since 2022Traded Aug 14 · filed 4 days later
Since the trade −36.6% · S&P 500 −2.8% · to Nov 13
The CFO of Aclarion paid $25K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month. Shares held went up 20% with this purchase.
Insider buying
4 insiders in a week, 3rd time since 2022Traded Aug 13 · filed 4 days later
Since the trade −35.0% · S&P 500 −3.0% · to Nov 13
An Aclarion director paid $50K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month. Shares held went up 38% with this purchase.
Insider buying
4 insiders in a week, 3rd time since 2022Traded Aug 13 · filed 4 days later
Since the trade −35.0% · S&P 500 −3.0% · to Nov 13
An Aclarion director paid $18K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month. Shares held went up 33% with this purchase.
Insider buying
4 insiders in a week, 3rd time since 2022Traded Aug 13 · filed 4 days later
Since the trade −35.0% · S&P 500 −3.0% · to Nov 13
The CEO of Aclarion paid $12K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month.
Insider buying
4 insiders in a week, 3rd time since 2022Traded Aug 13 · filed 4 days later
Since the trade −35.0% · S&P 500 −3.0% · to Nov 13
An Aclarion director paid $5K out of pocket for Aclarion shares. 5 other people at Aclarion bought some too, in the same month. Shares held went up 10% with this purchase.
Insider buying
3 insiders in a week, 2nd time since 2022Traded May 11 · filed 1 day later
Since the trade −49.7% · S&P 500 +2.0% · to Nov 13
An Aclarion director paid $7.8K out of pocket for Aclarion shares. 3 other people at Aclarion bought some too, in the same month. Shares held went up 125000% with this purchase.
Insider buying
4 insiders in a week, 2nd time since 2022Traded May 12 · filed the same day
Since the trade −50.5% · S&P 500 +2.2% · to Nov 13
An Aclarion director paid $18K out of pocket for Aclarion shares. 3 other people at Aclarion bought some too, in the same month.
Insider buying
3 insiders in a week, 2nd time since 2022Traded May 11 · filed the same day
Since the trade −49.7% · S&P 500 +2.0% · to Nov 13
The CEO of Aclarion paid $20K out of pocket for Aclarion shares. 3 other people at Aclarion bought some too, in the same month. It was the first purchase in 6 months.
Insider buying
First buy since 2022Traded May 6 · filed 2 days later
Since the trade −52.4% · S&P 500 +2.8% · to Nov 13
An Aclarion director paid $5.2K out of pocket for Aclarion shares. 3 other people at Aclarion bought some too, in the same month. Shares held went up 156200% with this purchase.
Insider buying
First insider buy since Feb 2023Traded Nov 26, 2025 · filed 5 days later
Since the trade −74.8% · S&P 500 +11.0% · to Nov 13
The CEO of Aclarion paid $62 out of pocket for Aclarion shares. Shares held went up 1000% with this purchase.
11 open-market purchases and 0 open-market sales by insiders of ACON between Apr 16, 2023 and today, placed against the company's last 4 earnings releases. The latest on file was filed Feb 21, 2024.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Feb 21, 2024 | None | None | None |
| Aug 25, 2023 | None | None | None |
| May 23, 2023 | None | None | None |
| May 16, 2023 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
